Abstract

Background: The EML4-ALK fusion oncogene is found in 2 to 7% of all non-small cell lung cancers, most of which are adenocarcinomas. ALK positive lung malignancies are rare; even more rare are primary ALK positive lung malignancies that metastasize to the breast.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call